# Study of UB-312 in Healthy Participants and Parkinson's Disease Patients

> **NCT04075318** · PHASE1 · COMPLETED · sponsor: **United Neuroscience Ltd.** · enrollment: 70 (actual)

## Conditions studied

- Parkinson's Disease
- Parkinsonism

## Interventions

- **BIOLOGICAL:** UB-312
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04075318
- **Lead sponsor:** United Neuroscience Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-29
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04075318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04075318, "Study of UB-312 in Healthy Participants and Parkinson's Disease Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04075318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*